Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study
- PMID:21606396
- DOI: 10.1161/CIRCULATIONAHA.110.988287
Arrhythmogenic right ventricular dysplasia/cardiomyopathy: pathogenic desmosome mutations in index-patients predict outcome of family screening: Dutch arrhythmogenic right ventricular dysplasia/cardiomyopathy genotype-phenotype follow-up study
Abstract
Background: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is an autosomal dominant inherited disease with incomplete penetrance and variable expression. Causative mutations in genes encoding 5 desmosomal proteins are found in ≈50% of ARVD/C index patients. Previous genotype-phenotype relation studies involved mainly overt ARVD/C index patients, so follow-up data on relatives are scarce.
Methods and results: One hundred forty-nine ARVD/C index patients (111 male patients; age, 49±13 years) according to 2010 Task Force criteria and 302 relatives from 93 families (282 asymptomatic; 135 male patients; age, 44±13 years) were clinically and genetically characterized. DNA analysis comprised sequencing of plakophilin-2 (PKP2), desmocollin-2, desmoglein-2, desmoplakin, and plakoglobin and multiplex ligation-dependent probe amplification to identify large deletions in PKP2. Pathogenic mutations were found in 87 index patients (58%), mainly truncating PKP2 mutations, including 3 cases with multiple mutations. Multiplex ligation-dependent probe amplification revealed 3 PKP2 exon deletions. ARVD/C was diagnosed in 31% of initially asymptomatic mutation-carrying relatives and 5% of initially asymptomatic relatives of index patients without mutation. Prolonged terminal activation duration was observed more than negative T waves in V(1) to V(3), especially in mutation-carrying relatives <20 years of age. In 45% of screened families, ≥1 affected relatives were identified (90% with mutations).
Conclusions: Pathogenic desmosomal gene mutations, mainly truncating PKP2 mutations, underlie ARVD/C in the majority (58%) of Dutch index patients and even 90% of familial cases. Additional multiplex ligation-dependent probe amplification analysis contributed to discovering pathogenic mutations underlying ARVD/C. Discovering pathogenic mutations in index patients enables those relatives who have a 6-fold increased risk of ARVD/C diagnosis to be identified. Prolonged terminal activation duration seems to be a first sign of ARVD/C in young asymptomatic relatives.
Comment in
- Arrhythmogenic right ventricular dysplasia/cardiomyopathy: a family affair.Judge DP.Judge DP.Circulation. 2011 Jun 14;123(23):2661-3. doi: 10.1161/CIRCULATIONAHA.111.031724.Circulation. 2011.PMID:21670239No abstract available.
Similar articles
- Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.Dalal D, James C, Devanagondi R, Tichnell C, Tucker A, Prakasa K, Spevak PJ, Bluemke DA, Abraham T, Russell SD, Calkins H, Judge DP.Dalal D, et al.J Am Coll Cardiol. 2006 Oct 3;48(7):1416-24. doi: 10.1016/j.jacc.2006.06.045. Epub 2006 Sep 12.J Am Coll Cardiol. 2006.PMID:17010805
- Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy.Hulot JS, Jouven X, Empana JP, Frank R, Fontaine G.Hulot JS, et al.Circulation. 2004 Oct 5;110(14):1879-84. doi: 10.1161/01.CIR.0000143375.93288.82. Epub 2004 Sep 27.Circulation. 2004.PMID:15451782Review.
- Prophylactic implantable defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia and no prior ventricular fibrillation or sustained ventricular tachycardia.Corrado D, Calkins H, Link MS, Leoni L, Favale S, Bevilacqua M, Basso C, Ward D, Boriani G, Ricci R, Piccini JP, Dalal D, Santini M, Buja G, Iliceto S, Estes NA 3rd, Wichter T, McKenna WJ, Thiene G, Marcus FI.Corrado D, et al.Circulation. 2010 Sep 21;122(12):1144-52. doi: 10.1161/CIRCULATIONAHA.109.913871. Epub 2010 Sep 7.Circulation. 2010.PMID:20823389
- Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.Bhonsale A, Groeneweg JA, James CA, Dooijes D, Tichnell C, Jongbloed JD, Murray B, te Riele AS, van den Berg MP, Bikker H, Atsma DE, de Groot NM, Houweling AC, van der Heijden JF, Russell SD, Doevendans PA, van Veen TA, Tandri H, Wilde AA, Judge DP, van Tintelen JP, Calkins H, Hauer RN.Bhonsale A, et al.Eur Heart J. 2015 Apr 7;36(14):847-55. doi: 10.1093/eurheartj/ehu509. Epub 2015 Jan 23.Eur Heart J. 2015.PMID:25616645
- Genetics of arrhythmogenic right ventricular cardiomyopathy.Campuzano O, Alcalde M, Allegue C, Iglesias A, García-Pavía P, Partemi S, Oliva A, Pascali VL, Berne P, Sarquella-Brugada G, Brugada J, Brugada P, Brugada R.Campuzano O, et al.J Med Genet. 2013 May;50(5):280-9. doi: 10.1136/jmedgenet-2013-101523. Epub 2013 Mar 6.J Med Genet. 2013.PMID:23468208Review.
Cited by
- Sudden Unexplained Nocturnal Death Syndrome: The Hundred Years' Enigma.Zheng J, Zheng D, Su T, Cheng J.Zheng J, et al.J Am Heart Assoc. 2018 Mar 3;7(5):e007837. doi: 10.1161/JAHA.117.007837.J Am Heart Assoc. 2018.PMID:29502107Free PMC article.Review.No abstract available.
- Genetic and toxicologic investigation of Sudden Cardiac Death in a patient with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) under cocaine and alcohol effects.Cittadini F, De Giovanni N, Alcalde M, Partemi S, Carbone A, Campuzano O, Brugada R, Oliva A.Cittadini F, et al.Int J Legal Med. 2015 Jan;129(1):89-96. doi: 10.1007/s00414-014-1119-5. Epub 2014 Nov 16.Int J Legal Med. 2015.PMID:25399050
- Clinical characterisation and risk stratification of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy ≥50 years of age.van der Pols MJ, Mast TP, Loh P, van der Heijden JF, Cramer MJ, Hauer RN, Te Riele AS.van der Pols MJ, et al.Neth Heart J. 2016 Dec;24(12):740-747. doi: 10.1007/s12471-016-0886-7.Neth Heart J. 2016.PMID:27580740Free PMC article.
- Risk Stratification in Arrhythmic Right Ventricular Cardiomyopathy Without Implantable Cardioverter-Defibrillators.Brun F, Groeneweg JA, Gear K, Sinagra G, van der Heijden J, Mestroni L, Hauer RN, Borgstrom M, Marcus FI, Hughes T.Brun F, et al.JACC Clin Electrophysiol. 2016 Oct;2(5):558-564. doi: 10.1016/j.jacep.2016.03.015. Epub 2016 Jun 1.JACC Clin Electrophysiol. 2016.PMID:27790640Free PMC article.
- Arrhythmogenic cardiomyopathy and Brugada syndrome: diseases of the connexome.Agullo-Pascual E, Cerrone M, Delmar M.Agullo-Pascual E, et al.FEBS Lett. 2014 Apr 17;588(8):1322-30. doi: 10.1016/j.febslet.2014.02.008. Epub 2014 Feb 15.FEBS Lett. 2014.PMID:24548564Free PMC article.Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical